Literature DB >> 2876184

Natural history of human immunodeficiency virus infection in Zaire.

J M Mann, K Bila, R L Colebunders, K Kalemba, N Khonde, N Bosenge, N Nzilambi, M Malonga, L Jansegers, H Francis.   

Abstract

The natural history of human immunodeficiency virus (HIV) infection in Zaïre was determined by identifying in October, 1984, 125 seropositive hospital personnel without signs or symptoms and 145 age and sex matched seronegative controls from the same population. Between July, 1985, and February, 1986, 67 seropositives, including 38 men and 29 women, and 113 seronegatives were interviewed and examined by an observer who did not know their serological status. The acquired immunodeficiency syndrome (AIDS) had developed in 1 seropositive and no seronegatives (rate difference, 1.3/100 person-years [py]; 95% confidence interval 0-3.3/100 py); AIDS-related complex or generalised lymphadenopathy had developed in 8 seropositives (12%) and 1 seronegative (1%) (rate ratio, 13.2; 95% confidence interval 1.3-134.6); and minimal lymphadenopathy had developed in 19 seropositives (28%) and 8 seronegatives (7%) (rate ratio, 3.9; 95% confidence interval 1.8-8.4). These data provide the first estimates for rates of progression to AIDS or AIDS-related conditions among healthy HIV seropositive heterosexual adults. Rates observed in this study are similar to those reported in US or European homosexual or bisexual men.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Data Analysis; Developing Countries; Diseases; French Speaking Africa; Hiv Infections; Middle Africa; Research Methodology; Signs And Symptoms; Viral Diseases; Zaire

Mesh:

Substances:

Year:  1986        PMID: 2876184     DOI: 10.1016/s0140-6736(86)90229-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.

Authors:  B Hofmann; B O Lindhardt; J Gerstoft; C S Petersen; P Platz; L P Ryder; N Odum; E Dickmeiss; P B Nielsen; S Ullman
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

2.  What use is a clinical case definition for AIDS in Africa?

Authors:  C F Gilks
Journal:  BMJ       Date:  1991-11-09

3.  Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study.

Authors:  Dilys Morgan; Cedric Mahe; Billy Mayanja; James A G Whitworth
Journal:  BMJ       Date:  2002-01-26

4.  Risk of HIV-related diseases in heterosexuals importing infection from Zaire.

Authors:  A Lazzarin; C Uberti Foppa; P Crocchiolo; P Verani; O Varnier; D Salvi
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

5.  The clinical features of HIV infection in Africa.

Authors:  R J Biggar
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

6.  HIV antibody screening among immigrants: a cost-benefit analysis.

Authors:  H Zowall; R D Fraser; N Gilmore; A Deutsch; S Grover
Journal:  CMAJ       Date:  1990-07-15       Impact factor: 8.262

7.  Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera.

Authors:  G Vercauteren; G van der Groen; P Piot
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

Review 8.  Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

9.  Heterosexual spread of human immunodeficiency virus in Edinburgh.

Authors:  A J France; C A Skidmore; J R Robertson; R P Brettle; J J Roberts; S M Burns; C A Foster; J M Inglis; W B Galloway; S J Davidson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

10.  Behavioural risk factors for acquisition of HIV infection and knowledge about AIDS among male professional blood donors in Delhi.

Authors:  D Chattopadhya; L W Riley; S Kumari
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.